Session » Antiphospholipid Syndrome
- 2:30PM-4:00PM
-
Abstract Number: 2761
Adenosine Receptor Agonism Protects Against Antiphospholipid Antibody-Mediated Netosis and Venous Thrombosis
- 2:30PM-4:00PM
-
Abstract Number: 2760
Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking (APS ACTION) Clinical Database and Repository (“Registry”) Analysis: First and Recurrent Thrombosis Risk after 1201 Patient-Years of Follow-up
- 2:30PM-4:00PM
-
Abstract Number: 2764
Gene Expression Profile in Monocytes of Antiphospholipid Syndrome Patients Reveals Novel Altered Genes and Pathways Involved in the Pathophysiology of the Disease
- 2:30PM-4:00PM
-
Abstract Number: 2763
mTORC1 Blockade with Rapamycin and N-Acetylcysteine Reduces Anti-Phospholipid Antibody Levels in Controlled Clinical Trials of Patients with SLE
- 2:30PM-4:00PM
-
Abstract Number: 2762
Study of 60 Patients with Intrauterine Fetal Deaths Related to Antiphospholipid Syndrome
- 2:30PM-4:00PM
-
Abstract Number: 2759
The Risk of Ischaemic Stroke in Primary APS Patients: A Prospective Study